SynthesisInternational journal of cancer2026

Risk-Benefit of Phase 2 Monotherapy Trials in Adult Solid Cancers: A Systematic Review and Meta-Analysis.

Charlotte Ouimet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.